advertisement

---

Chen V 16

Showing records 1 to 16 | Display all abstracts from Chen V

117681 Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Kim S
Ophthalmology science 2024; 4: 100533

---

118736 Injectable, Antioxidative, and Tissue-Adhesive Nanocomposite Hydrogel as a Potential Treatment for Inner Retina Injuries
Liu YC; Lin YK
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2308635

---

117681 Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Chen V; Pottenburgh J; Pottenburgh J
Ophthalmology science 2024; 4: 100533

---

118736 Injectable, Antioxidative, and Tissue-Adhesive Nanocomposite Hydrogel as a Potential Treatment for Inner Retina Injuries
Lin YT; Lin CW
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2308635

---

117681 Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Cruz M
Ophthalmology science 2024; 4: 100533

---

118736 Injectable, Antioxidative, and Tissue-Adhesive Nanocomposite Hydrogel as a Potential Treatment for Inner Retina Injuries
Lan GY
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2308635

---

117681 Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Cooper G
Ophthalmology science 2024; 4: 100533

---

118736 Injectable, Antioxidative, and Tissue-Adhesive Nanocomposite Hydrogel as a Potential Treatment for Inner Retina Injuries
Su YC
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2308635

---

117681 Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Sun C
Ophthalmology science 2024; 4: 100533

---

118736 Injectable, Antioxidative, and Tissue-Adhesive Nanocomposite Hydrogel as a Potential Treatment for Inner Retina Injuries
Hu FR
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2308635

---

117681 Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Im L
Ophthalmology science 2024; 4: 100533

---

118736 Injectable, Antioxidative, and Tissue-Adhesive Nanocomposite Hydrogel as a Potential Treatment for Inner Retina Injuries
Chang KH
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2308635

---

117681 Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Magder L
Ophthalmology science 2024; 4: 100533

---

118736 Injectable, Antioxidative, and Tissue-Adhesive Nanocomposite Hydrogel as a Potential Treatment for Inner Retina Injuries
Chen V
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2308635

---

117681 Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Saeedi OJ
Ophthalmology science 2024; 4: 100533

---

118736 Injectable, Antioxidative, and Tissue-Adhesive Nanocomposite Hydrogel as a Potential Treatment for Inner Retina Injuries
Yeh YC; Chen TC; Yu J
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2308635

---